Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for hair loss show promise, but more development is needed, especially for tough cases.

Topical prostaglandin E2 can help treat both alopecia areata and vitiligo.

A married couple both developed alopecia areata, possibly due to shared stress.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

People with certain types of hair loss, especially lichen planopilaris and telogen effluvium, as well as African Americans, Asians, and men, are more likely to have severe vitamin D deficiency.

Alopecia areata and androgenetic alopecia affect quality of life similarly.

Low-level laser therapy can stimulate hair growth more effectively than fake devices, but patient satisfaction is similar for both. Results should be taken with caution due to small study sizes and differences between studies. More research is needed.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Vitamin D receptor gene variations are not linked to alopecia areata.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

Dupilumab for skin problems might reactivate hair loss in some patients.

Platelet-Rich Plasma and stem cell therapy can increase hair count and density, but the best method for preparation and treatment still needs to be determined.

PRP is effective for hair loss and might work better with other treatments, but more research is needed.

Certain IL-18 gene variations may increase the risk of alopecia areata.

Adult acne severity is influenced by stress, skin sensitivity, makeup, stopping oral contraceptives, and requires female-specific treatment guidelines.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Low vitamin D levels are common in people with Alopecia Areata.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Low-Level Laser Therapy and other light treatments for hair growth lack strong evidence and need more research.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Some people with chronic hair loss may have thyroid autoimmunity.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

The A allele of the C2 gene increases the risk of lupus, while the G allele may protect against it.